title: Silencing of Pokemon enhances caspase-dependent apoptosis via fas- and mitochondria-mediated pathways in hepatocellular carcinoma cells.
abstract: The role of Pokemon (POK erythroid myeloid ontogenic actor), a recently identified POK transcription factor with proto-oncogenic activity, in hepatocellular carcinogenesis has only been assessed by a few studies. Our previous study revealed that Pokemon is overexpressed in hepatocellular carcinomas (HCC) and promotes HCC cell proliferation and migration via an AKT- and ERK- dependent manner. In the present study, we used the TUNEL assay and FACS analysis to demonstrate that oxaliplatin induced apoptosis was significantly increased in cells with silenced Pokemon. Western blots showed that p53 expression and phosphorylation were significantly increased in Pokemon defective cells, thereby initiating the mitochondria-mediated and death receptor-mediated apoptotic pathways. In the mitochondria-mediated pathway, expression of pro-apoptotic Bcl-2 family members (including Bad, Bid, Bim and Puma) as well as AIF was increased and decreasing the mitochondrial membrane potential resulted in cytochrome C released from mitochondrial in HepG2 si-Pokemon cells. In addition, upon oxaliplatin treatment of Pokemon-silenced cells, the FAS receptor, FADD and their downstream targets caspase-10 and caspase-8 were activated, causing increased release of caspase-8 active fragments p18 and p10. Increased activated caspase-8-mediated cleavage and activation of downstream effector caspases such as caspase-9 and caspase-3 was observed in HepG2 si-Pokemon cells as compared to control. Therefore, Pokemon might serve as an important mediator of crosstalk between intrinsic and extrinsic apoptotic pathways in HCC cells. Moreover, our findings suggest that Pokemon could be an attractive therapeutic target gene for human cancer therapy.
authors.affiliation: Department of Gastroenterology, Zhongshan Hospital affiliated to Xiamen University, Xiamen, China.
authors.forename: Yu-Qin
authors.initials: YQ
authors.lastname: Zhang
authors.forename: Chuan-Xing
authors.initials: CX
authors.lastname: Xiao
authors.forename: Bi-Yun
authors.initials: BY
authors.lastname: Lin
authors.forename: Ying
authors.initials: Y
authors.lastname: Shi
authors.forename: Yun-Peng
authors.initials: YP
authors.lastname: Liu
authors.forename: Jing-Jing
authors.initials: JJ
authors.lastname: Liu
authors.forename: Bayasi
authors.initials: B
authors.lastname: Guleng
authors.forename: Jian-Lin
authors.initials: JL
authors.lastname: Ren
mesh_terms: D017209:Apoptosis; D001483:Base Sequence; D006528:Carcinoma, Hepatocellular / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology; D020169:Caspases / Q000378:metabolism*; D045744:Cell Line, Tumor; D017931:DNA Primers; D004268:DNA-Binding Proteins / Q000235:genetics*; D020868:Gene Silencing; D006801:Humans; D020287:In Situ Nick-End Labeling; D008113:Liver Neoplasms / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology; D008930:Mitochondria, Liver / Q000378:metabolism*; D014157:Transcription Factors / Q000235:genetics*; D019014:fas Receptor / Q000378:metabolism*
chemical_list: D017931:DNA Primers; D004268:DNA-Binding Proteins; C491901:FAS protein, human; D014157:Transcription Factors; C485514:ZBTB7A protein, human; D019014:fas Receptor; D020169:Caspases